scispace - formally typeset
P

Per Rugaard Poulsen

Researcher at Aarhus University Hospital

Publications -  183
Citations -  4255

Per Rugaard Poulsen is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Multileaf collimator & Fiducial marker. The author has an hindex of 37, co-authored 168 publications receiving 3581 citations. Previous affiliations of Per Rugaard Poulsen include Royal North Shore Hospital & University of Sydney.

Papers
More filters
Journal ArticleDOI

The first clinical implementation of electromagnetic transponder-guided MLC tracking.

TL;DR: The real-time beam-target correction method, electromagnetic transponder-guided MLC tracking, has been translated to the clinic and represents a milestone in improving geometric and dosimetric accuracy, and by inference treatment outcomes, in cancer radiotherapy.
Journal ArticleDOI

First demonstration of combined kV/MV image-guided real-time dynamic multileaf-collimator target tracking.

TL;DR: For the first time, a complete tracking system combining kV/MV image-guided target tracking and DMLC beam tracking was demonstrated and is a promising method for intrafraction motion management.
Journal ArticleDOI

Toward submillimeter accuracy in the management of intrafraction motion: the integration of real-time internal position monitoring and multileaf collimator target tracking.

TL;DR: A research version of a novel four-dimensional delivery system that integrates nonionizing radiation-based internal position monitoring and accurate real-time DMLC-based beam adaptation is developed, representing a significant step toward achieving the eventual goal of geometrically ideal dose delivery to moving tumors.
Journal ArticleDOI

Kilovoltage intrafraction monitoring for prostate intensity modulated arc therapy: first clinical results.

TL;DR: This is the first use of KIM in a prospective clinical study of prostate cancer patients undergoing intensity modulated arc therapy (IMAT), and key advantages of this method are submillimeter accuracy, widespread applicability, and a low barrier to clinical implementation.